Timely vaccination is the best way to protect ourselves from serious vaccine-preventable diseases. So book ahead, make an appointment with your doctor.
Download as PDF

Childhood vaccines

Age Disease Vaccine Information
Birth Hepatitis B

H-B-Vax II (IM)

OR

Engerix B (IM)

 Within 7 days of birth
(ideally within 24 hours)
6 weeks Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio

Infanrix Hexa (IM)

OR

Vaxelis(IM)
Pneumococcal Prevenar 13 (IM)
Rotavirus Rotarix (Oral) Dose 1 limited to 6-14 weeks of age
Meningococcal B (Aboriginal1 children only) Bexsero (IM) Prophylactic paracetamol recommended. Catch up available for Aboriginal children <2 years
4 months Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio

Infanrix Hexa (IM)

OR

Vaxelis(IM)
Pneumococcal Prevenar 13 (IM)
Rotavirus Rotarix (Oral) Dose 2 limited to 10-24 weeks
Meningococcal B (Aboriginal children only) Bexsero (IM) Prophylactic paracetamol recommended. Catch up available for Aboriginal children <2 years
6 months Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio

Infanrix Hexa (IM)

OR

Vaxelis(IM)

 Children ≥6 months with at risk conditions for invasive pneumococcal disease are recommended to receive an additional dose of Prevenar 13 – see the Australian Immunisation Handbook.

Aboriginal children ≥6 months with certain at risk conditions may require an additional dose of Bexsero – see the Australian Immunisation Handbook.
12 months Meningococcal ACWY Nimenrix (IM)
Pneumococcal Prevenar 13 (IM)
Measles, mumps, rubella MMR II OR Priorix (IM or SC)
Meningococcal B (Aboriginal children only) Bexsero (IM) Prophylactic paracetamol recommended. Catch up available for Aboriginal children <2 years
18 months Diphtheria, tetanus, pertussis Infanrix OR Tripacel (IM)
Measles, mumps, rubella, varicella Priorix Tetra OR Proquad (IM or SC)
Haemophilus influenzae type b ACT-HIB (IM or SC)
4 years Diphtheria, tetanus, pertussis, polio

Infanrix-IPV (IM)

OR

 Quadracel (IM)

 Children with at risk conditions for invasive pneumococcal disease are recommended to receive an additional dose of Pneumovax 23 – see the Australian Immunisation Handbook

At risk groups, adolescents and adults

Age/Condition Disease Vaccine Information
All people with asplenia, hyposplenia, complement deficiency and treatment with eculizumab Meningococcal ACWY Nimenrix (IM) See the Australian Immunisation Handbook for required doses and timing
Additional groups are recommended to receive these vaccines but these are not funded
Meningococcal B Bexsero (IM)
>5 years with asplenia or hyposplenia Haemophilus influenzae type b ACT-HIB (IM or SC) If incompletely vaccinated or not vaccinated in childhood
Year 7 Diphtheria, tetanus, pertussis Boostrix (IM)
Human papillomavirus Gardasil 9 (IM)
Year 10 Meningococcal ACWY Nimenrix (IM)
Pregnant Influenza Influenza      Any trimester
Pertussis

Boostrix OR Adacel (IM)

      Each pregnancy between 20-32 weeks
Aboriginal people ≥50 years
 P​neumococcal



Zoster
 Prevenar 13 (IM) then​
Pneumovax23 ​(IM)​ 
Shingrix (IM)
        Prevenar 13: ≥50 years
       Pneumovax 23: 2-12 months later
       Pneumovax 23: at least 5 years later
≥​65 years
Zoster
Shingrix (IM)

​70 years
 ​​Pneumococcal                  Prevenar 13 (IM)               Pneumococcal funded for people ≥70
People with at risk conditions for invasive pneumococcal disease See the Australian Immunisation ​Handbook for conditions recommended to receive Prevenar 13 and Pneumovax 23

Influenza

Age/At risk condition Recommendation Information
All children 6 months <5 years Annual influenza vaccination Discuss influenza vaccination with other present family members. For vaccine brands and eligibility see Seasonal influenza vaccination.
Aboriginal people ≥6 months
People with at risk conditions ≥6 months
≥65 years
Pregnant women

Notes

  1. The term Aboriginal is inclusive of Aboriginal and Torres Strait Islander people.

​​​

Current as at: Friday 27 October 2023
Contact page owner: Immunisation